Fundraising FoxRidgeback Capital — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Receptosreceptos.cominFeb 2012Acquired
San Diego biopharmaceutical company developing GPCR-targeted immune-inflammatory drugs; acquired by Celgene for ~$7.2B in 2015.
BiotechSan Diego, US
Marcus Boehm(Executive Officer)inRobert Peach(Executive Officer)inRaymond Stevens(Director)inFaheem Hasnain(Executive Officer, Director)inJames Schmidt(Executive Officer)inChrysa Mineo(Executive Officer)in
Co-investorsARCH Venture PartnersOUP (Osage University Partners)VenrockLilly Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.